NIKSFARMA+, OOO, Moscow Oblast

Economic indicators

Net profit (RAS) of NIKSFARMA+, OOO grew over 2023 1.57 times to 3.06 million RUB from 1.95 million RUB over 2022, the company informed.

Revenue decreased in the accounting period by 17.10% to 27.50 million RUB from 33.17 million RUB in 2022.

Net profit (RAS) of NIKSFARMA+, OOO dropped in 2022 by 49.92% to 1.95 million RUB from 3.89 million RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period by 46.64% to 33.17 million RUB from 62.16 million RUB in 2021.

Net profit (RAS) of NIKSFARMA+, OOO dropped in 2021 by 44.79% to 3.89 million RUB from 7.05 million RUB over the same period in 2020, the company informed.

Revenue decreased in the accounting period by 2.64% to 62.16 million RUB from 63.85 million RUB in 2020.

Net profit (RAS) of NIKSFARMA+, OOO grew over 2020 by 27.19% to 7.05 million RUB from 5.54 million RUB over 2019, the company informed.

Revenue increased in the accounting period by 27.49% to 63.85 million RUB from 50.08 million RUB over 2019.

Net profit (RAS) of NIKSFARMA+, OOO grew over 2019 by 28.44% to 5.54 million RUB from 4.32 million RUB over 2018, the company informed.

Revenue increased in the accounting period by 27.45% to 50.08 million RUB from 39.30 million RUB over 2018.

Net profit (RAS) of NIKSFARMA+, OOO grew over 2018 2.84 times to 4.32 million RUB from 1.52 million RUB over 2017, the company informed.

Revenue increased in the accounting period 3.64 times to 39.30 million RUB from 10.78 million RUB over 2017; cost of goods sold grew 3.77 times to 34.30 million RUB from 9.09 million RUB; sales profit went up 2.95 times to 5.00 million RUB from 1.69 million RUB.

Companies in the region

• MIR UVLECHENIY
• NEFTEPRODUKTY
• SFERA
• MUDRA
• BIZNES LAYN